Andreas H. Kottmann,Lauren Malave,Heike Rebholz,Eitan Friedman
申请号：
US15425435
公开号：
US20170224643A1
申请日:
2017.02.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Certain neurological disorders are treated with dopamine agonists (e.g. L-Dopa) but these treatments unintentionally cause Levodopa-induced dyskinesias (LIDs) or tardive dyskinesia. An improved treatment is described that treats the patient with both a dopamine agonist and a Smoothened (Smo) agonist or with a dopamine agonist and combination of a Smoothened (Smo) agonist together with Amantadine.
